Early and quantal (by litter) expression of insulin autoantibodies in the nonobese diabetic mice predict early diabetes onset

被引:42
|
作者
Melanitou, E [1 ]
Devendra, D [1 ]
Liu, E [1 ]
Miao, DM [1 ]
Eisenbarth, GS [1 ]
机构
[1] Univ Colorado, Hlth Sci Ctr, Barbara Davis Ctr Childhood Diabet, Denver, CO 80262 USA
来源
JOURNAL OF IMMUNOLOGY | 2004年 / 173卷 / 11期
关键词
D O I
10.4049/jimmunol.173.11.6603
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Aiming to study the early stages of type 1 diabetes phenotype, before insulitis appears, we measured insulin autoantibodies (IAA) between 3 and 5 wk of age in the NOD mouse (early-IAA (E-IAA)). We report that IAA are found as early as at 3 wk of age, at weaning, and their expression is a quantal phenotype. Maternal autoantibody status influences this early phenotype, because animals of litters issued from IAA-positive ante partum mothers develop E-IAA with a significantly higher incidence than animals issued from IAA-negative mothers. These E-IAA represent synthesized rather than transplacental autoantibodies, as evidenced by higher levels in many offspring compared with maternal IAA, and negative as well as positive offspring in the same litters and it correlates with early diabetes onset, defining the first autoimmune window in diabetes pathogenesis. Therefore, autoimmune processes leading to type I diabetes initiate early in life, are influenced by maternal autoantibody status, and can be revealed by the presence of IAA. Our data suggest that the mechanisms responsible for the breakdown of self-tolerance are subjected not only to genetic predisposition, but also to the physiological status of the mother. Pathological progression to autoimmunity is marked by the presence of immunological windows relating early steps with final disease onset.
引用
收藏
页码:6603 / 6610
页数:8
相关论文
共 50 条
  • [1] Elimination of maternally transmitted autoantibodies prevents diabetes in nonobese diabetic mice
    Greeley, SAW
    Katsumata, M
    Yu, LP
    Eisenbarth, GS
    Moore, DJ
    Goodarzi, H
    Barker, CF
    Naji, A
    Noorchashm, H
    NATURE MEDICINE, 2002, 8 (04) : 399 - 402
  • [2] Elimination of maternally transmitted autoantibodies prevents diabetes in nonobese diabetic mice
    Siri Atma W. Greeley
    Makoto Katsumata
    Liping Yu
    George S. Eisenbarth
    Daniel J. Moore
    Heidi Goodarzi
    Clyde F. Barker
    Ali Naji
    Hooman Noorchashm
    Nature Medicine, 2002, 8 : 399 - 402
  • [3] LONGITUDINAL-STUDY OF ISLET CELL ANTIBODIES AND INSULIN AUTOANTIBODIES AND DEVELOPMENT OF DIABETES IN NONOBESE DIABETIC (NOD) MICE
    REDDY, S
    BIBBY, N
    ELLIOTT, RB
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1990, 81 (03): : 400 - 405
  • [4] E2f1 mutation induces early onset of diabetes and Sjogren's syndrome in nonobese diabetic mice
    Salam, MA
    Matin, K
    Matsumoto, N
    Tsuha, Y
    Hanada, N
    Senpuku, H
    JOURNAL OF IMMUNOLOGY, 2004, 173 (08): : 4908 - 4918
  • [5] Exendin-4 modulates diabetes onset in nonobese diabetic mice
    Hadjiyanni, Irene
    Baggio, Laurie L.
    Poussier, Philippe
    Drucker, Daniel J.
    ENDOCRINOLOGY, 2008, 149 (03) : 1338 - 1349
  • [6] STUDIES OF AUTOANTIBODIES REACTIVE WITH THYROID MEMBRANE-ANTIGENS AND INSULIN IN NONOBESE DIABETIC MICE
    BERNARD, NF
    ERTUG, F
    MARGOLESE, H
    AUTOIMMUNITY, 1992, 13 (02) : 159 - 164
  • [7] Evidence of early determination of subsequent diabetes in NOD mice: Expression of high affinity anti-insulin autoantibodies
    Abiru, N
    Yu, LP
    Robles, DT
    Kelemen, K
    Eisenbarth, GS
    DIABETES, 2000, 49 : A81 - A81
  • [8] Early neonatal events and the disease incidence in nonobese diabetic mice
    Dahlquist, G
    Kallen, B
    PEDIATRIC RESEARCH, 1997, 42 (04) : 489 - 491
  • [9] Early Neonatal Events and the Disease Incidence in Nonobese Diabetic Mice
    Gisela Dahlquist
    Bengt Källén
    Pediatric Research, 1997, 42 : 489 - 491
  • [10] BCG VACCINE REVERSES NEW-ONSET DIABETES IN NONOBESE DIABETIC MICE
    PEK, SB
    GUYTINGCO, RR
    BRANCH, J
    SWIRCZEK, JM
    BROWN, MB
    DIABETOLOGIA, 1992, 35 : A217 - A217